EGFR and head and neck squamous cell carcinoma: If, in the early stages, the therapeutic success rate is relatively high, for LA-HNSCC cases treated by combining radiotherapy with Cisplatin or Anti-EGFR (epidermal growth factor receptor) Cetuximab, 40% of cases will not respond to treatment.